| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/14/1999 | WO1999003508A9 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/14/1999 | WO1999002183A3 A method of inducing a ctl response |
| 05/14/1999 | WO1999000407A3 Improved bacillus thuringiensis toxin |
| 05/14/1999 | WO1998058965A3 B7-binding molecules for treating immune diseases |
| 05/14/1999 | WO1998053838A3 A soluble laminin receptor precursor and methods to inhibit its interactions |
| 05/14/1999 | WO1998051697A3 Method for producing polymers having nucleo-bases as side-groups |
| 05/14/1999 | WO1998047917A9 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2 |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/14/1999 | WO1997006272A3 High efficiency helper system for aav vector production |
| 05/14/1999 | CA2845178A1 .alpha.-amylase mutants |
| 05/14/1999 | CA2309005A1 Murd protein and gene of streptococcus pyogenes |
| 05/14/1999 | CA2308610A1 Heparin cofactor ii preparation and process therefor |
| 05/14/1999 | CA2308575A1 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 05/14/1999 | CA2308565A1 Sequences for targeting metastatic cells |
| 05/14/1999 | CA2308299A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | CA2308277A1 Hemoglobin with chemically introduced disulfide cross-links and preparation thereof |
| 05/14/1999 | CA2308136A1 Method for administering acylated insulin |
| 05/14/1999 | CA2308119A1 .alpha.-amylase mutants |
| 05/14/1999 | CA2308112A1 Caspase-14 polypeptides |
| 05/14/1999 | CA2308029A1 Reagents and methods useful for detecting diseases of the breast |
| 05/14/1999 | CA2308017A1 A method of inhibiting an immune response to a recombinant vector |
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/14/1999 | CA2307622A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 05/14/1999 | CA2307541A1 Encapsulated immunomodulators useful as vaccine adjuvants |
| 05/14/1999 | CA2307380A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma |
| 05/14/1999 | CA2304981A1 Rho family antagonists and their use to block inhibition of neurite outgrowth |
| 05/14/1999 | CA2304830A1 A gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocina |
| 05/14/1999 | CA2276685A1 Suppressor of cytokine signaling |
| 05/13/1999 | CA2253119A1 Hydrophilizing agent precursor, a process for its preparation and its use as a dispersing agent for aqueous polyurethane dispersion |
| 05/12/1999 | EP0915168A1 Process for producing maturation bone morphogenetic protein |
| 05/12/1999 | EP0915166A1 DNA virus vectors and methods for their production |
| 05/12/1999 | EP0915165A1 Method for the helper virus-free packaging of a DNA-vector |
| 05/12/1999 | EP0915162A2 Adenine phosphoribosyltransferase |
| 05/12/1999 | EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae |
| 05/12/1999 | EP0915158A2 Improvements in or relating to detection of salmonella |
| 05/12/1999 | EP0915157A2 Method for the preparation of functional recombinant tissue factor |
| 05/12/1999 | EP0915156A1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/12/1999 | EP0915155A1 Novel signal transducer |
| 05/12/1999 | EP0915154A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 05/12/1999 | EP0915101A1 New synthetic polypeptide |
| 05/12/1999 | EP0915100A1 Novel protein |
| 05/12/1999 | EP0915099A1 Antiparallel oligopeptides and hydrophobically complementary oligopeptides, matrices containing them and use thereof in the purification and detection of subtypes of alpha interferon |
| 05/12/1999 | EP0914829A1 Preventives and/or remedies for multiple organ failure |
| 05/12/1999 | EP0914614A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrP?c AND PrP?sc |
| 05/12/1999 | EP0914613A1 Dp and e2f protein nuclear localisation signals and their use |
| 05/12/1999 | EP0914611A1 Leptin assay |
| 05/12/1999 | EP0914610A1 Screen for ecdysone receptor ligands |
| 05/12/1999 | EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 05/12/1999 | EP0914458A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus |
| 05/12/1999 | EP0914457A1 Methods and compositions for transforming cells |
| 05/12/1999 | EP0914456A1 Gene expression in monocytes and macrophages |
| 05/12/1999 | EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF |
| 05/12/1999 | EP0914452A2 Novel ptp20, pcp-2, bdp1, clk and sirp proteins and related products and methods |
| 05/12/1999 | EP0914445A1 Non-a-non-e hepatitis virus having a translatable core region, reagents and methods for their use |
| 05/12/1999 | EP0914444A1 Vectors comprising sar elements |
| 05/12/1999 | EP0914443A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection |
| 05/12/1999 | EP0914442A1 Avian polynucleotide vaccine formula |
| 05/12/1999 | EP0914441A2 Novel human cytomegalovirus dna constructs and uses therefor |
| 05/12/1999 | EP0914440A1 Nucleic acid vaccination for parvoviral infections |
| 05/12/1999 | EP0914439A2 Pesticidal toxins |
| 05/12/1999 | EP0914438A1 Recombinant sef14 fimbrial protein from salmonella |
| 05/12/1999 | EP0914437A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/12/1999 | EP0914436A1 Plant retinoblastoma-associated proteins |
| 05/12/1999 | EP0914435A1 Hybrid interferon compositions and methods of use |
| 05/12/1999 | EP0914433A2 Kv potassium channel polypeptides and polynucleotides |
| 05/12/1999 | EP0914432A2 Secreted proteins and polynucleotides encoding them |
| 05/12/1999 | EP0914431A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 05/12/1999 | EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 05/12/1999 | EP0914429A1 Polynucleotides encoding secreted proteins from human pbmc |
| 05/12/1999 | EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 05/12/1999 | EP0914427A1 Plasmid-based vaccine for treating atherosclerosis |
| 05/12/1999 | EP0914426A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 05/12/1999 | EP0914425A1 Recombinant nucleic acid sequences coding for proteins with at least one hydrophobic domain, and uses thereof |
| 05/12/1999 | EP0914424A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 05/12/1999 | EP0914423A2 Inhibition of hiv-1 replication by antisense rna expression |
| 05/12/1999 | EP0914422A1 Mammalian genes involved in viral infection and tumor suppression |
| 05/12/1999 | EP0914419A1 Transgenic mammals capable of expressing leukemia inhibitory factor |
| 05/12/1999 | EP0914347A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 05/12/1999 | EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES |
| 05/12/1999 | EP0914344A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 05/12/1999 | EP0914343A1 Nucleotide sequence typical for a deletion of proto-oncogene ret in exon 11 |
| 05/12/1999 | EP0914342A2 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth |
| 05/12/1999 | EP0914341A1 Antagonists of intestinotrophic glp-2 peptides |
| 05/12/1999 | EP0914340A1 hGH-RH(1-29)NH 2? ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914338A2 Cell growth regulatory genes |
| 05/12/1999 | EP0914337A2 Secreted proteins |
| 05/12/1999 | EP0914336A2 Secreted proteins |
| 05/12/1999 | EP0914335A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 05/12/1999 | EP0914333A1 Peptide derivatives |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914325A1 Modulators of the function of fas receptors and other proteins |
| 05/12/1999 | EP0914150A1 Recombinant neospora antigens and their uses |
| 05/12/1999 | EP0914148A1 Treatment of partial growth hormone insensitivity syndrome |
| 05/12/1999 | EP0914146A1 Morphogen treatment for chronic renal failure |
| 05/12/1999 | EP0914145A1 Methods of controlling axonal growth |
| 05/12/1999 | EP0914144A1 Therapeutic uses of bpi protein products for human meningococcemia |
| 05/12/1999 | EP0914142A1 Peptides with increased binding affinity for hla molecules |